Pharmaceutical development of microbicide drug products.
about
A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu miceA review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Evaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 Prevention.Retrocyclins and their activity against HIV-1.Update on microbicide research and development - seeking new HIV prevention tools for women.UC781 microbicide gel retains anti-HIV activity in cervicovaginal lavage fluids collected following twice-daily vaginal applicationMicrobicides for the Treatment of Sexually Transmitted HIV Infections.Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis.3-hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate against HIV type 1 entry by targeting both viral envelope glycoprotein gp120 and cellular receptor CD4.An intravaginal ring for the simultaneous delivery of multiple drugs.Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.Hibiscus sabdariffa L. and Its Bioactive Constituents Exhibit Antiviral Activity against HSV-2 and Anti-enzymatic Properties against Urease by an ESI-MS Based Assay.Thermosensitive Gel Containing Cellulose Acetate Phthalate-Efavirenz Combination Nanoparticles for Prevention of HIV-1 Infection.Evaluation of microporous polycaprolactone matrices for controlled delivery of antiviral microbicides to the female genital tract.High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women.Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents.Advances in vaginal drug delivery.Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial.Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.
P2860
Q28478394-9DA03203-88B3-4CB3-B8E4-517293FF1A0CQ30431343-91E1526B-E3E7-464A-99BB-95C4F82D17E5Q34785687-C86F9AAF-227F-424E-928E-DA352148A672Q35879590-6B59887B-F879-4479-A2BE-B575C562B9E6Q35958928-99684837-AE29-4406-830A-F21C70BDED11Q36086344-D22BF01B-963C-437F-A447-C5F3F05A7A91Q36112191-F8257580-9CB9-4D59-BCEA-146CD1419E85Q36442232-363101BB-03E9-4D95-AA7A-5863064A9AC3Q37258274-C3CED447-7436-4325-846C-02AE1C09C234Q37379716-726C9C41-231F-42C0-A209-3AFD649D0B1EQ37990037-ED3AEEDB-A27B-4708-A900-D9920F6BC233Q38260862-120599EB-EF08-475A-94B7-607B145F91A3Q39265131-2E0B2A98-8A17-4049-9B9E-EC488965A9D6Q40216950-F259629A-3051-40C4-8568-1F20664F061FQ41033215-1C8F729E-BD3A-4766-8C07-728C19D1A4E5Q42280939-65AB870D-6EE1-4058-940E-DECB99980FC3Q43938869-0B0D6112-E51B-4FDA-9B45-1711832E7BC7Q44792283-147C0904-0402-4732-96CA-4CF515DB638CQ45010865-5D06621E-65B7-40A5-BE4C-0F2C26AAB791Q55119981-7B30A30B-8D12-40C7-8E91-838CF337E234Q55338133-C71FF5E3-2443-4AF2-A404-1D0798A186E6
P2860
Pharmaceutical development of microbicide drug products.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmaceutical development of microbicide drug products.
@en
Pharmaceutical development of microbicide drug products.
@nl
type
label
Pharmaceutical development of microbicide drug products.
@en
Pharmaceutical development of microbicide drug products.
@nl
prefLabel
Pharmaceutical development of microbicide drug products.
@en
Pharmaceutical development of microbicide drug products.
@nl
P2860
P1476
Pharmaceutical development of microbicide drug products.
@en
P2093
David R Friend
P2860
P304
P356
10.3109/10837450903369879
P577
2009-12-17T00:00:00Z